Doctor From Brigham and Women’s Hospital Discussed Impact Of Stratasys 3D Printing In Facial Transplants

MINNEAPOLIS & REHOVOT, Israel--(BUSINESS WIRE)--Stratasys Ltd. (Nasdaq:SSYS), a global leader of 3D printing and additive manufacturing solutions, announced that Dr. Frank J. Rybicki, the director of Applied Imaging Science Laboratory at Brigham and Women’s Hospital, discussed the impact of Stratasys 3D printing for a full-face transplant patient at the 2014 Radiological Society of North America (RSNA) annual meeting in Chicago today.

Help employers find you! Check out all the jobs and post your resume.
MORE ON THIS TOPIC